Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide.
about
Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.Effect of particle size on oral bioavailability of darunavir-loaded solid lipid nanoparticles.Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs
P2860
Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Development of solid lipid nan ...... availability of glibenclamide.
@en
type
label
Development of solid lipid nan ...... availability of glibenclamide.
@en
prefLabel
Development of solid lipid nan ...... availability of glibenclamide.
@en
P2093
P50
P1476
Development of solid lipid nan ...... availability of glibenclamide.
@en
P2093
C Ghelardini
L Di Cesare Mannelli
P356
10.1016/J.EJPB.2016.02.012
P407
P577
2016-02-27T00:00:00Z